nasdaq:neos
|
393088
|
Mar 23rd, 2024 12:00AM
|
Neos Therapeutics, Inc.
|
4.2K
|
35.00
|
Open
|
|
Mar 22nd, 2024 11:59PM
|
Mar 23rd, 2024 07:08PM
|
Neos Therapeutics, Inc. is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Neos, which is initially focusing on the treatment of ADHD, has two other branded product candidates that are XR medications in ODT or oral suspension dosage forms.
Contact: HR@NeosTX.com
|
Open
|
|
Open
|
2940 N State Highway 360
|
Grand Prairie
|
TX
|
US
|
75050
|
|
Neos Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:neos
|
393088
|
Mar 22nd, 2024 12:00AM
|
Neos Therapeutics, Inc.
|
4.2K
|
35.00
|
Open
|
|
Mar 21st, 2024 11:49PM
|
Mar 22nd, 2024 06:56PM
|
Neos Therapeutics, Inc. is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Neos, which is initially focusing on the treatment of ADHD, has two other branded product candidates that are XR medications in ODT or oral suspension dosage forms.
Contact: HR@NeosTX.com
|
Open
|
|
Open
|
2940 N State Highway 360
|
Grand Prairie
|
TX
|
US
|
75050
|
|
Neos Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:neos
|
393088
|
Mar 21st, 2024 12:00AM
|
Neos Therapeutics, Inc.
|
4.2K
|
35.00
|
Open
|
|
Mar 21st, 2024 12:02AM
|
Mar 21st, 2024 05:40PM
|
Neos Therapeutics, Inc. is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Neos, which is initially focusing on the treatment of ADHD, has two other branded product candidates that are XR medications in ODT or oral suspension dosage forms.
Contact: HR@NeosTX.com
|
Open
|
|
Open
|
2940 N State Highway 360
|
Grand Prairie
|
TX
|
US
|
75050
|
|
Neos Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:neos
|
393088
|
Mar 20th, 2024 12:00AM
|
Neos Therapeutics, Inc.
|
4.2K
|
35.00
|
Open
|
|
Mar 20th, 2024 12:43AM
|
Mar 20th, 2024 07:41PM
|
Neos Therapeutics, Inc. is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Neos, which is initially focusing on the treatment of ADHD, has two other branded product candidates that are XR medications in ODT or oral suspension dosage forms.
Contact: HR@NeosTX.com
|
Open
|
|
Open
|
2940 N State Highway 360
|
Grand Prairie
|
TX
|
US
|
75050
|
|
Neos Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:neos
|
393088
|
Mar 19th, 2024 12:00AM
|
Neos Therapeutics, Inc.
|
4.2K
|
35.00
|
Open
|
|
Mar 18th, 2024 11:38PM
|
Mar 19th, 2024 06:13PM
|
Neos Therapeutics, Inc. is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Neos, which is initially focusing on the treatment of ADHD, has two other branded product candidates that are XR medications in ODT or oral suspension dosage forms.
Contact: HR@NeosTX.com
|
Open
|
|
Open
|
2940 N State Highway 360
|
Grand Prairie
|
TX
|
US
|
75050
|
|
Neos Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:neos
|
393088
|
Mar 18th, 2024 12:00AM
|
Neos Therapeutics, Inc.
|
4.2K
|
35.00
|
Open
|
|
Mar 17th, 2024 11:59PM
|
Mar 18th, 2024 07:26PM
|
Neos Therapeutics, Inc. is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Neos, which is initially focusing on the treatment of ADHD, has two other branded product candidates that are XR medications in ODT or oral suspension dosage forms.
Contact: HR@NeosTX.com
|
Open
|
|
Open
|
2940 N State Highway 360
|
Grand Prairie
|
TX
|
US
|
75050
|
|
Neos Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:neos
|
393088
|
Mar 16th, 2024 12:00AM
|
Neos Therapeutics, Inc.
|
4.2K
|
35.00
|
Open
|
|
Mar 15th, 2024 11:29PM
|
Mar 16th, 2024 07:13PM
|
Neos Therapeutics, Inc. is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Neos, which is initially focusing on the treatment of ADHD, has two other branded product candidates that are XR medications in ODT or oral suspension dosage forms.
Contact: HR@NeosTX.com
|
Open
|
|
Open
|
2940 N State Highway 360
|
Grand Prairie
|
TX
|
US
|
75050
|
|
Neos Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:neos
|
393088
|
Mar 15th, 2024 12:00AM
|
Neos Therapeutics, Inc.
|
4.2K
|
35.00
|
Open
|
|
Mar 15th, 2024 01:13AM
|
Mar 15th, 2024 09:03AM
|
Neos Therapeutics, Inc. is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Neos, which is initially focusing on the treatment of ADHD, has two other branded product candidates that are XR medications in ODT or oral suspension dosage forms.
Contact: HR@NeosTX.com
|
Open
|
|
Open
|
2940 N State Highway 360
|
Grand Prairie
|
TX
|
US
|
75050
|
|
Neos Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:neos
|
393088
|
Mar 14th, 2024 12:00AM
|
Neos Therapeutics, Inc.
|
4.2K
|
35.00
|
Open
|
|
Mar 13th, 2024 11:27PM
|
Mar 14th, 2024 12:24PM
|
Neos Therapeutics, Inc. is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Neos, which is initially focusing on the treatment of ADHD, has two other branded product candidates that are XR medications in ODT or oral suspension dosage forms.
Contact: HR@NeosTX.com
|
Open
|
|
Open
|
2940 N State Highway 360
|
Grand Prairie
|
TX
|
US
|
75050
|
|
Neos Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:neos
|
393088
|
Mar 13th, 2024 12:00AM
|
Neos Therapeutics, Inc.
|
4.2K
|
35.00
|
Open
|
|
Mar 12th, 2024 11:22PM
|
Mar 13th, 2024 10:55AM
|
Neos Therapeutics, Inc. is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Neos, which is initially focusing on the treatment of ADHD, has two other branded product candidates that are XR medications in ODT or oral suspension dosage forms.
Contact: HR@NeosTX.com
|
Open
|
|
Open
|
2940 N State Highway 360
|
Grand Prairie
|
TX
|
US
|
75050
|
|
Neos Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|